secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vivani Medical, Inc. (VANI)
CIK:        0001266806
Form:       8-K
Filed at:   2026-07-16T12:30:30+00:00
Accession:  0001753926-26-001190
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vivani Medical expects first dosing of SLIM-1 in August 2026
------------------------------------------------------------

- CEO Dr. Adam Mendelsohn presented at Emerging Growth Conference on July 15, 2026.
- First dosing of SLIM-1 clinical trial now expected in August 2026.
- Slide presentation used at conference attached as Exhibit 99.1.
- No other material financial or operational updates disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1266806/000175392626001190/0001753926-26-001190-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1266806/000175392626001190/vani-20260715.htm
  HTML page:      https://secwatch.observer/filing/0001753926-26-001190

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer